Visualization of the Stomach During Fasting and Measurement of Intragastric Volume After Ingestion of Fluid: Feasibility and Application of Three Dimensional Ultrasound in Healthy Subjects
ECHO3DGASTRIQ
1 other identifier
observational
6
1 country
1
Brief Summary
Aspiration pneumonia is a dreaded complication of anaesthesia because of its prevalence (1/3,886 cases in elective anaesthesia and 1/895 cases in emergency settings) and its high morbidity and mortality (3 to 9%). This chemical and/or infectious pneumonia is secondary to passage of the gastric contents into the unprotected upper airways during general anaesthesia. The prognosis depends on three factors: the presence of food debris, and the acidity and volume of the gastric contents. To prevent this complication, the French society of anaesthesia and intensive care recommends preoperative fasting rules and, in patients presenting risk factors for aspiration, the use of antacids and rapid sequence intubation. This preventive strategy is associated with certain adverse events: deferred operative procedures, discomfort and hypoglycaemia secondary to fasting, more frequent anaphylactic complications, and memory of anaesthetic induction. Over recent years, ultrasound has become more widely used by anaesthetists for local anaesthesia, vascular catheterization, haemodynamic monitoring and, more recently, 2D ultrasound estimation of intragastric volume. However, 2D ultrasound estimation of intragastric volume presents several limitations: because of the complex shape of the stomach, this technique requires a long learning curve and the measured volume is poorly correlated with reference techniques (MRI and 99Tc scintigraphy). Two studies have recently measured intragastric volume by three dimensional ultrasound with promising results.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 28, 2016
CompletedFirst Posted
Study publicly available on registry
June 30, 2016
CompletedJune 30, 2016
June 1, 2016
2.2 years
June 28, 2016
June 28, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
success rate of ultrasound visualization of the stomach while fasting
success rate of ultrasound visualization of the stomach while fasting
Day 0
Secondary Outcomes (4)
ultrasound visualization of the fasting stomach learning curve
Day 0
measured difference of antral surface area
Day 0
absolute error of the volume measured
Day 0
relative error of the volume measured
Day 0
Study Arms (1)
volunteers
Healthy volunteers over the age of 18 years employed by Amiens University Hospital 3D echography
Interventions
Eligibility Criteria
Healthy volunteers fasting
You may qualify if:
- Healthy volunteers over the age of 18 years employed by Amiens University Hospital and covered by French national health insurance.
- Fasting (last meal \> 6 hours and last drink of water, tea or coffee \> 2 hours)
- Signature of the free and informed written consent form.
You may not qualify if:
- Pregnant woman.
- Presence of diseases or treatments that alter (slow or accelerate) gastric emptying.
- Presence of swallowing disorders.
- History of gastric or supramesocolic surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens
Amiens, 80054, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edouard SECQ, PhD
CHU Amiens
- PRINCIPAL INVESTIGATOR
Emmanuel LORNE, MD, PhD
CHU Amiens
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2016
First Posted
June 30, 2016
Study Start
April 1, 2013
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
June 30, 2016
Record last verified: 2016-06